DAFNA Capital Management as of Sept. 30, 2023
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 75 positions in its portfolio as reported in the September 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr S&p Biotech Etf Etf (XBI) | 12.8 | $41M | 565k | 73.02 | |
Stereotaxis Com New (STXS) | 6.7 | $22M | 14M | 1.58 | |
Cytokinetics Com New (CYTK) | 4.4 | $14M | 480k | 29.46 | |
Ideaya Biosciences (IDYA) | 4.2 | $14M | 500k | 26.98 | |
Revolution Medicines (RVMD) | 4.1 | $13M | 473k | 27.68 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 4.0 | $13M | 136k | 93.64 | |
Ishares Nasdaq Biotech Indx Etf (IBB) | 3.9 | $13M | 103k | 122.29 | |
Blueprint Medicines (BPMC) | 3.9 | $13M | 250k | 50.22 | |
Merus N V (MRUS) | 3.6 | $11M | 485k | 23.58 | |
Xenon Pharmaceuticals (XENE) | 3.0 | $9.6M | 281k | 34.16 | |
Karuna Therapeutics Ord | 2.8 | $8.9M | 53k | 169.09 | |
Neurocrine Biosciences (NBIX) | 2.6 | $8.3M | 74k | 112.50 | |
Day One Biopharmaceuticals I (DAWN) | 2.2 | $7.2M | 587k | 12.27 | |
Syndax Pharmaceuticals (SNDX) | 2.1 | $6.7M | 458k | 14.52 | |
Dex (DXCM) | 2.0 | $6.3M | 68k | 93.30 | |
Kalvista Pharmaceuticals (KALV) | 1.8 | $5.8M | 606k | 9.63 | |
2seventy Bio Common Stock (TSVT) | 1.8 | $5.7M | 1.4M | 3.92 | |
AtriCure (ATRC) | 1.7 | $5.5M | 126k | 43.80 | |
Morphic Hldg (MORF) | 1.7 | $5.3M | 232k | 22.91 | |
Kura Oncology (KURA) | 1.6 | $5.0M | 551k | 9.12 | |
Axogen (AXGN) | 1.5 | $4.7M | 936k | 5.00 | |
BioCryst Pharmaceuticals (BCRX) | 1.4 | $4.6M | 652k | 7.08 | |
Tandem Diabetes Care Com New (TNDM) | 1.4 | $4.6M | 221k | 20.77 | |
Nurix Therapeutics (NRIX) | 1.4 | $4.4M | 557k | 7.86 | |
Alector (ALEC) | 1.3 | $4.1M | 629k | 6.48 | |
Mirati Therapeutics | 1.3 | $4.0M | 93k | 43.56 | |
Arcus Biosciences Incorporated (RCUS) | 1.2 | $4.0M | 223k | 17.95 | |
Ascendis Pharma A/s Note 2.250% 4/0 (Principal) | 1.1 | $3.7M | 4.0M | 0.92 | |
Viking Therapeutics (VKTX) | 1.1 | $3.5M | 320k | 11.07 | |
Accuray Incorporated (ARAY) | 1.0 | $3.3M | 1.2M | 2.72 | |
Edgewise Therapeutics (EWTX) | 0.9 | $3.0M | 519k | 5.73 | |
Mediwound Shs New (MDWD) | 0.9 | $2.7M | 258k | 10.64 | |
Century Therapeutics (IPSC) | 0.8 | $2.6M | 1.3M | 2.00 | |
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.8 | $2.5M | 122k | 20.09 | |
Amylyx Pharmaceuticals (AMLX) | 0.7 | $2.2M | 123k | 18.31 | |
Procept Biorobotics Corp (PRCT) | 0.7 | $2.2M | 67k | 32.81 | |
Astria Therapeutics (ATXS) | 0.7 | $2.2M | 296k | 7.46 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.7 | $2.2M | 928k | 2.33 | |
Keros Therapeutics (KROS) | 0.7 | $2.1M | 66k | 31.88 | |
Galapagos Nv Spon Adr (GLPG) | 0.6 | $2.1M | 60k | 34.55 | |
Third Harmonic Bio (THRD) | 0.6 | $1.9M | 300k | 6.39 | |
Brainsway Sponsored Ads (BWAY) | 0.5 | $1.7M | 432k | 4.04 | |
Regulus Therapeutics (RGLS) | 0.5 | $1.5M | 1.1M | 1.37 | |
Compass Pathways Sponsored Ads (CMPS) | 0.4 | $1.4M | 193k | 7.40 | |
Cerevel Therapeutics Hldng I (CERE) | 0.4 | $1.4M | 62k | 21.83 | |
ImmunoGen | 0.4 | $1.3M | 83k | 15.87 | |
Larimar Therapeutics (LRMR) | 0.4 | $1.3M | 327k | 3.95 | |
Spruce Biosciences (SPRB) | 0.4 | $1.3M | 570k | 2.26 | |
Mereo Biopharma Group Spon Ads (MREO) | 0.4 | $1.2M | 963k | 1.29 | |
Gossamer Bio (GOSS) | 0.4 | $1.2M | 1.5M | 0.83 | |
Proqr Therapeutics N V Shs Euro (PRQR) | 0.4 | $1.2M | 941k | 1.30 | |
Macrogenics (MGNX) | 0.4 | $1.2M | 259k | 4.66 | |
Cullinan Oncology (CGEM) | 0.4 | $1.2M | 127k | 9.05 | |
Adicet Bio (ACET) | 0.3 | $1.1M | 797k | 1.37 | |
Iteos Therapeutics (ITOS) | 0.3 | $1.1M | 99k | 10.95 | |
Syros Pharmaceuticals Com New (SYRS) | 0.3 | $1.1M | 266k | 3.95 | |
Sutro Biopharma (STRO) | 0.3 | $982k | 283k | 3.47 | |
Mersana Therapeutics (MRSN) | 0.3 | $932k | 734k | 1.27 | |
Vigil Neuroscience (VIGL) | 0.3 | $929k | 172k | 5.39 | |
Biohaven (BHVN) | 0.3 | $910k | 35k | 26.01 | |
Immunovant (IMVT) | 0.3 | $864k | 23k | 38.39 | |
Acrivon Therapeutics Common Stock (ACRV) | 0.2 | $735k | 77k | 9.56 | |
Nevro (NVRO) | 0.2 | $538k | 28k | 19.22 | |
Neuronetics (STIM) | 0.1 | $424k | 314k | 1.35 | |
Elevation Oncology (ELEV) | 0.1 | $298k | 450k | 0.66 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $274k | 351k | 0.78 | |
Masimo Corporation (MASI) | 0.1 | $263k | 3.0k | 87.68 | |
Karyopharm Therapeutics (KPTI) | 0.1 | $258k | 193k | 1.34 | |
Compass Therapeutics (CMPX) | 0.1 | $230k | 117k | 1.97 | |
Nextcure (NXTC) | 0.1 | $214k | 166k | 1.29 | |
Compugen Ord (CGEN) | 0.1 | $191k | 205k | 0.93 | |
Spero Therapeutics (SPRO) | 0.0 | $151k | 125k | 1.21 | |
Kinnate Biopharma | 0.0 | $147k | 105k | 1.40 | |
Inogen (INGN) | 0.0 | $78k | 15k | 5.22 | |
Acelyrin (SLRN) | 0.0 | $74k | 7.3k | 10.17 |